Bertrand Loy is President & CEO of Entegris Inc.
Person profile
Roles
Entegris
President & CEO
Harvard Bioscience
Director
Address
Billerica, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Feb 23 | ENTG Entegris | Common Stock | Payment of exercise | Dispose F | No | No | 85.48 | 14,126 | 1.21 mm | 238,546 |
13 Feb 23 | ENTG Entegris | Common Stock | Payment of exercise | Dispose F | No | No | 84.94 | 8,727 | 741.27 k | 252,672 |
13 Feb 23 | ENTG Entegris | Common Stock | Grant | Acquire A | No | No | 0 | 19,676 | 0.00 | 261,399 |
31 Jan 23 | ENTG Entegris | Common Stock | Grant | Acquire A | No | No | 0 | 51,292 | 0.00 | 241,723 |
31 Jan 23 | ENTG Entegris | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 80.71 | 91,704 | 7.40 mm | 91,704 |
6 Sep 22 | HBIO Harvard Bioscience | Common Stock | Other | Dispose J | Yes | No | 0 | 108,715 | 0.00 | 0 |
26 Aug 22 | HBIO Harvard Bioscience | Common Stock | Buy | Acquire P | No | No | 3.41 | 9,291 | 31.68 k | 399,651 |